Cabaletta Bio, Inc.
CABA
$3.51
-$0.12-3.31%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -5.13% | -18.19% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.54% | 1.49% | |||
| Operating Income | 8.54% | -1.49% | |||
| Income Before Tax | 6.57% | 0.58% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 6.57% | 0.58% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.57% | 0.58% | |||
| EBIT | 8.54% | -1.49% | |||
| EBITDA | 8.61% | -1.77% | |||
| EPS Basic | 8.82% | 39.85% | |||
| Normalized Basic EPS | 8.83% | 39.84% | |||
| EPS Diluted | 8.82% | 39.85% | |||
| Normalized Diluted EPS | 8.83% | 39.84% | |||
| Average Basic Shares Outstanding | 2.48% | 65.27% | |||
| Average Diluted Shares Outstanding | 2.48% | 65.27% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||